Distribution of Poly- and Perfluoroalkyl Substances in Matched Samples from Pregnant Women and Carbon Chain Length Related Maternal Transfer

Citations Over TimeTop 10% of 2013 papers

Abstract

Although levels of poly- and perfluoroalkyl substances (PFASs) in human maternal and neonatal blood have been widely reported in the literature, relationship of maternal-fetal transmission of PFASs with carbon chain length is presently not well understood. In this study, 11 PFASs were analyzed in matched samples, including not only maternal blood (MB, n = 31) and cord blood (CB, n = 30), but also placenta (n = 29) and amniotic fluid (AF, n = 29). Except for perfluorohexanoic acid (PFHxA), the detection frequencies of PFASs were similar among placenta, MB, and CB (>80% for 8 PFASs, nondetectable for 2 PFASs). Though only perfluorooctanoic acid (PFOA) was frequently detected (>90%) in AF, with a median concentration of 0.043 ng/mL, other 5 PFASs were also detectable in AF samples with low concentrations (mean: 0.013-0.191 ng/mL). This suggests that in addition to blood-borne in utero exposure, the fetus is also exposed to low levels of PFASs through AF. Concentrations of PFOA in AF were positively correlated with those in MB (r = 0.738, p < 0.01) and CB (r = 0.683, p < 0.001), suggesting that AF concentration could reflect fetal PFOA exposure during pregnancy and can be used as a biomarker. To clarify the effects of carbon chain length on maternal transfer of PFASs, we calculated maternal transfer efficiencies of PFASs from MB to CB (TMB-CB). A U-shaped trend in TMB-CB of C7-C12 perfluoroalkyl carboxylic acids (PFCAs) with increasing carbon chain length was found in this study for the first time. The U-shaped TMB-CB of PFCAs with carbon chain length is an integrated result of opposite trend of the ratios between MB/placenta and placenta/CB based on carbon chain length. This is the first study to report the occurrence of PFASs in human placenta. The results reported here enable better understanding of the maternal-fetal transmission of PFASs.

Related Papers

• → Strategies for synthesizing non-bioaccumulable alternatives to PFOA and PFOS(2015)53 cited
• → Dietary exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS): a review of recent literature(2017)24 cited
• → Factors Influencing Pulmonary Surfactant Protein A Levels in Cord Blood, Maternal Blood and Amniotic Fluid(1998)15 cited
• → IN-UTERO DETECTION OF TYPE-II GLYCOGENOSIS (POMPE'S DISEASE)(1969)81 cited
• → Comparison of the Lipids in Maternal and Cord Blood and of Human Amniotic Fluid.(1962)22 cited